Molecular diversity of the dopamine receptors

Annual Review of Pharmacology and Toxicology

Volumn 33, Issue , 1993, Pages 281-307

  Civelli, Olivier ^a   Bunzow, James R ^a   Grandy, David K ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

D1 D2 D3, D4 D5; G protein coupled receptors; Parkinson's disease; Schizophrenia

Indexed keywords

2 DIPROPYLAMINO 5 METHOXY 1 METHYLTETRALIN; 5 METHOXY 1 METHYL 2 PROPYLAMINOTETRALIN; 8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; CLOZAPINE; DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; DOPAMINE 3 RECEPTOR; DOPAMINE RECEPTOR; DOPAMINE RECEPTOR AFFECTING AGENT; GUANINE NUCLEOTIDE BINDING PROTEIN; HALOPERIDOL; RECEPTOR SUBTYPE; SPIPERONE;

DOPAMINERGIC SYSTEM; GENE EXPRESSION; HUMAN; LIGAND BINDING; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; REVIEW; SCHIZOPHRENIA; SIGNAL TRANSDUCTION; TISSUE DISTRIBUTION;

EID: 0027411750     PISSN: 00664251     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev.pa.33.040193.001433     Document Type: Review

References (130)

1. Ehringer, H., Hornykiewicz, O. 1960. Verteilung von Noradrenalin und Dopamin (3-Hydroxytyramin) im Gehirn des Menschen und ihr Verhalten bei Erkrankungen des Extrapyramidalen Systems. Klin. Wochenschr. 38:1236-39
2. Birkmayer, W., Hornykiewicz, O. 1962. Der L-Dioxyphenylalanin (=L-DOPA)-Effekt beim Parkinson-Syndrom des Menschen: Zur Pathogenese and Behandlung der Parkinson-Akinese. Arch. Psychiat. Nervenkr. 203:560-74
3. Hornykiewicz, O. 1966. Dopamine and brain function. Pharmacol. Res. 18: 925-64
4. Carlsson, A., Lindqvist, M. 1963. Effect of chlorpromazine and haloperidol on the formation of 3-methoxytyramine in mouse brain. Acta Pharmacol. 20: 140-44
5. Carlsson, A. 1988. The current status of the dopamine hypothesis of schizophrenia. Neuropsycopharmology 1:179-86
6. Creese, I., Burt, D. R., Snyder, S. H. 1976. Dopamine receptor binding predicts clinical and pharmacological potencies of antischizophrenic drugs. Science 192:481-83
7. Seeman, P., Lee, T., Chan-Wong, M., Wong, K. 1976 . Antipsychotic drug doses and neuroleptic/dopamine receptors. Nature 261:717-19
8. Seeman, P. 1987. Dopamine receptors and the dopamine hypothesis of schizophrenia. Synapse 1:133-52
9. Kebabian, J. W., Calne, D. B. 1979. Multiple receptors for dopamine. Nature 277:93-96
10. Civelli, O., Bunzow, J. R., Grandy, D. K., Zhou, Q. Y., Van Tol, H. M. M. 1991. Molecular biology of the dopamine receptors. Eur. J. Pharmacol. 207:277-86
11. Grandy, D. K., Civelli, O. 1992. G-protein-coupled receptors: The new dopamine receptor subtypes. Curr. Opin. Neurobiol. In press
12. Sibley, D. R., Monsma, F. J. Jr. 1992. Molecular biology of dopamine receptors. Trends Pharmacol. Sci. 13:61-69
13. Dohlman, H. G., Caron, M. G., Lefkowitz, R. J. 1987. A family of receptors coupled to guanine nucleotide regulatory proteins. Biochemistry 26: 2657-64
14. Hall, Z. A. 1987. Three of a kind: The β-adrenergic receptor, the muscarinic acetylcholine receptor, and rhodopsin. Trends Neurolog. Sci. 10: 99-100
15. Probst, W. C., Snyder, L. A., Schuster, D. I., Brosius, J., Sealfon, S. C. 1992. Sequence alignment of the G protein-coupled receptor superfamily. DNA Cell Biol. 11:1-20
16. Dixon, R. A. F., Koblika, B. K., Strader, D. J., Benovic, J. L., Dolhman, H. G., et al. 1986. Cloning of the gene and cDNA for mammalian β-adrenergic receptor and homology with rhodopsin. Nature 321:75-79
17. Masu, Y., Nakayama, K., Tamaki, H., Harada, Y., Kuno, M., et al. 1987. cDNA cloning of bovine substance-k receptor through oocyte expression system. Nature 329:836-38
18. Kubo, T., Maeda, A., Sugimoto, K., Akiba, I., Mikami, A., et al. 1986. Primary structure of porcine cardiac muscarinic acetylcholine receptor deduced from the cDNA sequence. FEBS Lett. 209:367-72
19. 2 muscarinic receptor. Science 236:600-5
20. Bonner, T. I., Buckley, N. J., Young, A. C., Brann, M. R. 1987. Identification of a family of muscarinic acetylcholine receptor genes. Science 237: 527-32
21. Bunzow, J. R., Zhou, Q. Y., Civelli, O. 1992. Cloning of dopamine receptors: Homology approach. Meth. Neurosci. 9:441-53
22. 2 dopamine receptor cDNA. Nature 336:783-87
23. 2 receptor to inhibition of adenylyl cyclase and prolactin secretion. J. Biol. Chem. 265: 2098-104
24. 2 receptor cDNA expressed in mammalian cell lines. Mol. Pharmacol. 36:446-51
25. 2receptor gene is located on chromosome 11 at q22-q23 and identifies a Taq1 RFLP. Am. J. Hum. Genet. 45:778-85
26. 1 dopamine receptors. Nature 347:76-80
27. 1 receptor encoded by an intronless gene on chromosome 5. Nature 347:80-83
28. 1 dopamine receptor linked to adenylyl cyclase activation. Proc. Natl. Acad. Sci. USA 87:6723-27
29. 1 dopamine receptor. Nature 347:72-76
30. 1 dopamine receptor gene is located on chromosome 5 at q35.1 and identifies an EcoRI RFLP. Am. J. Hum. Genet. 47:828-34
31. Sokoloff, P., Giros, B., Martres, M. P., Boulhenet, M. L., Schwartz, J. C. 1990. Molecular cloning and characterization of a novel dopamine receptor (D3) as a target for neuroleptics. Nature 347:146-51
32. 3 humain et identification de son chromosome. C. R. Acad. Sci. 311:501-8
33. 4 receptor gene with high affinity for the antipsychotic clozapine. Nature 350:610-14
34. 4 dopamine receptor (DRD4) maps to distal 11p close to HRAS. Genomics 13:208-10
35. 1. Nature 350:614-19
36. 5 dopamine receptor genes: A functional receptor and two pseudogenes. Proc. Natl. Acad. Sci. USA 88:9175-79
37. 1 receptor. Proc. Natl. Acad. Sci. USA 88:7491-95
38. 5 dopamine receptor gene to human chromosome 4p15.1-p15.3, centromeric to the Huntington's disease locus. Genomics 12:510-16
39. 1 dopamine receptor. Mol. Pharmacol. 27: 184-92
40. 2 classification. Trends Pharmacol. Sci. 11:231-36
41. 2 dopamine receptor. Proc. Natl. Acad. Sci. USA 86:9762-66
42. Julius, D. 1991. Molecular biology of serotonin receptors. Annu. Rev. Neurosci. 14:335-60
43. Deleted in proof
44. Dohlman, H. G., Thorner, J., Caron, M. C., Lefkowitz, R. J. 1991. Model systems for the study of seven-transmembrane-segment receptors. Annu. Rev. Biochem. 60:653-88
45. 2-adrenergic receptor. J. Biol. Chem. 264:7564-69
46. 2 dopamine receptor. Trends Neurolog. Sci. 13:373-78
47. Bates, M. D., Gingrich, J. A., Bunzow, J. R., Falardeau, P., Dearry, A., et al. 1990. Molecular characterization of dopamine receptors. Am. J. Hyperten. 3:295-305
48. Hibert, M. R., Trumpp-Kallmeyer, S., Bruinvels, A., Hoflack, J. 1991. Three-dimensional models of neurotransmitter G-binding protein-coupled receptors. Mol. Pharmacol. 40:8-15
49. Dixon, R. A. F., Sigal, I. S., Vandelore, M. R., Register, R. B., Scattergood, W., et al. 1987. Structural features required for ligand binding to the β-adrenergic receptor. EMBO J. 6:3269
50. Strader, C. O., Candelore, M. R., Hill, W. S., Sigal, I. S., Dixon, R. A. F. 1989. Identification of two serine residues involved in agonist activation of the β-adrenergic receptor. J. Biol. Chem. 264:13572-78
51. 2 receptor. J. Biol. Chem. In press
52. Strader, C. D., Sigal, I. S., Register, R. B., Candelore, M. R., Rands, E., et al. 1987. Identification of residues required for ligand binding to the β-adrenergic receptor. Proc. Natl. Acad. Sci. USA 84:4384-88
53. Strader, C. D., Sigal, I. S., Candelore, M. R., Rands, E., Hill, W. S., et al. 1988. Conserved aspartic acid residues 79 and 113 of the β-adrenergic receptor have different roles in receptor function. J. Biol. Chem. 263:10267-71
54. 2receptor affinity for drugs and inhibition of adenylyl cyclase. Mol. Pharmacol. 39:733-39
55. Dixon, R. A. F., Sigal, I. S., Strader, C. D. 1988. Structure-function analysis of the β-adrenergic receptor. Cold Spring Harbor Symp. 53:487-98
56. Lefkowitz, R. J., Kobilka, B. K., Benovic, J. L., Bouvier, M., Cotecchia, S., et al. 1988. Molecular biology of adrenergic receptors. Cold Spring Harbor Symp. 53:507-14
57. O'Dowd, B. F., Lefkowitz, R. J., Caron, M. G. 1989 . Structure of the adrenergic and related receptors. Annu. Rev. Neurosci. 12:67-83
58. Memo, M., Lovenberg, W., Habauer, I. 1982. Agonists-induced subsensitivity of adenylate cyclase coupled with a dopamine receptor in slices from rat corpus striatum. Proc. Natl. Acad. Sci. USA 79:4456-60
59. Wolf, M. E., Roth, R. H. 1987. Dopamine autoreceptors. In Dopamine Receptors, ed. I. Creese, C. M. Fraser, pp. 45-96. New York: Liss
60. 2 dopamine receptor mRNAs in rat brain. Neuropsychopharmacology 5:231-42
61. 2 receptor binding in the rat brain and pituitary: an in situ hybridization-receptor audoradiographic analysis. J. Neurosci. 10:2587-600
62. 2dopamine receptor mRNA in brain of normal mice and mice lesioned with 6-hydroxydopamine. Neuropharmacology 30:927-41
63. 2 dopamine receptor-regulated gene expression of striatonigral and striatopallidal neurons. Science 250:1429-30
64. 2 receptor mRNA and opioid systems. In The International Narcotics Research Conference (INRC), pp. 227-30. New York: Liss
65. 2 receptor. Trends Pharmacol. Sci. 10:74-77
66. 2 receptors expressed in different cell types. J. Biol. Chem. 265:1032-1036
67. Deleted in proof
68. Deleted in proof
69. 2 dopamine receptors mediate the potentiation of arachidonic acid release in Chinese hamster ovary cells. Mol. Pharmacol. 39:364-69
70. 2 muscarinic receptor subtype coupled to both adenylyl cyclase and phosphoinositide turnover. Science 238:672-75
71. Ashkenazi, A., Peralta, E. G., Winslow, J. W., Ramachandran, J., Capon, D. J. 1989. Functional diversity of muscarinic recpetor subtypes in cellular signal transduction and growth. Trends Pharmacol. Sci. 10:16-22 (Suppl.)
72. 1 muscarinic receptors mediate both adenylate cyclase inhibition and phosphoinositide turnover. EMBO J. 7:3031-35
73. Rens-Domiano, S., Law, S., Yamada, Y., Seino, S., Belle, G. I., et al. 1992. Pharmacological properties of two cloned somatostatin receptors. Mol. Pharmacol. In press
74. 1A dopamine receptor gene. Proc. Natl. Acad. Sci. USA 89:3045-49
75. 1 receptor gene. J. Neurochem. In press
76. 1 dopamine receptors in various forebrain regions of the rat. Neurosci. Lett. 81:183-87
77. 2-adrenergic receptor gene confers transcriptional autoregulation by cAMP. J. Biol. Chem. 265:19330-35
78. Hershey, A. D., Dykema, P. E., Krause, J. E. 1991. Organization, structure, and expression of the gene encoding the rat substance P receptor. J. Bio. Chem. 266:4366-74
79. 2 dopamine receptors as a function of aging and chronic reserpine treatment following irreversible modification: A key to receptor regulatory mechanisms. J. Neurosci. 7:1484-91
80. 2 dopamine receptor mRNA level. Neurosci. Lett. 111:303-8
81. 2 receptor mRNAs in rat brain. J. Mol. Neurosci. 2:155-61
82. Le Moine, C., Normand, E., Guitteny, A. F., Fouque, B., Teoule, R., et al. 1990. Dopamine receptor gene express by enkephalin neurons in rat forebrain. Proc. Natl. Acad. Sci. USA 87:230-34
83. Autelitano, D. J., Snyder, L., Sealfon, S. C., Roberts, J. L. 1989 . Dopamine D2-receptor messenger RNA is differentially regulated by dopaminergic agents in rat anterior and neurointermediate pituitary. Mol. Cell. Endocrinol. 67:101-5
84. 2 dopamine receptor mRNA after denervation. Proc. Natl. Acad. Sci. 88:2802-6
85. 2 receptor isoforms in various cerebral tissues. J. Neurochem. 58:673-79
86. 2 dopamine receptor mRNA in rat brain. Proc. Natl. Acad. Sci. USA 86:7625-28
87. 2 receeptor in the rat brain by in situ hybridization histochemistry. Proc. Natl. Acad. Sci. USA 86:8560-64
88. 2 dopaminergic receptor detected by in situ hybridization histochemistry in rat brain. FEBS Lett. 255:335-39
89. 2 receptor mRNA in rat brain. FEBS Lett. 253:207-13
90. 1 dopamine receptor mRNA in brain supports a role in cognitive, affective, and neuroendocrine aspects of dopaminergic neurotransmission. Proc. Natl. Acad. Sci. USA 88:3772-76
91. Meador-Woodruff, J. H., Mansour, A., Grandy, D. K., Civelli, O., Watson, S. J. 1992. Distribution of D5 dopamine receptor mRNA in rat brain. FEBS Lett. In press
92. Van Tol, H. M. M., Wu, C. M., Guan, H. C., Ohara, K., Bunzow, J. R., et al. 1992. Multiple dopamine D4 receptor variants in the human population. Nature 358:149-52
93. Deleted in proof
94. Felder, R. A., Felder, C. A., Eisner, F. M., Jose, P. A. 1989. The dopamine receptor in adult and maturing kidney. Am. Physiol. J. F315-27
95. Deleted in proof
96. 4 receptor: Sequence, gene, structure, and demonstration of expression in the cardiovascular system. New Biol. 4:137-46
97. 2 dopamine receptor systems: Their role in the regulation of psychomoter behavior, putative mechanisms, and clinical relevance. J. Psychopharmacol. 3:54-63
98. 2 agonist effects. Science 269:719-22
99. 2 dopamine receptors is reduced in schizophrenia and Huntington diseased brain. Proc. Natl. Acad. Sci. USA 86:10156-60
100. 2 dopamine receptor synergism. Nature 347:386-88
101. Orkin, S. M., Kazazian, H. H., Autorarakis, S. E., Goff, S. C., Boehm, C., et al. 1982. Linkage of beta-thalassaemia mutations and beta-globin gene polymorphisms with DNA polymorphisms in human beta-globin gene cluster. Nature 296:627-31
102. Treisman, R., Orkin, S. H., Maniatis, T. 1983. Specific transcription and RNA splicing defects in five cloned β-thalassaemia genes. Nature 302:591-96
103. Mahadevan, M., Tsilfidis, C., Sabourin, L., Shutler, G., Amemiya, C., et al. 1992. Myotonic dystrophy mutation: An unstable CTG repeat in the 3′ untranslated region of the gene. Science 255:1253-55
104. Fu, Y. H., Pizzuti, A., Fenwick, R. G. Jr., King, J., Rajnarayan, S., et al. 1992. An unstable triplet repeat in a gene related to myotonic muscular dystrophy. Science 255:1256-58
105. 2A subtype. DNA 8:683-89
106. 2 receptor: Two molecular forms generated by alternative splicing. EMBO J. 8:4025-34
107. 2 dopamine receptor isoforms. Nature 342:923-26
108. 2 dopamine receptors produced by alternative RNA splicing. Nature 342:926-29
109. 2 dopamine receptor in rat and bovine caudate nucleus. Nature 343:266-69
110. 2 receptor. Biochem. Biophys. Res. Commun. 166: 109-12
111. 2A receptor gene: Identification of alternative transcripts and a variant donor splice site. Biochemistry 29: 1367-71
112. 2B subtypes in a heterologous cell line. Mol. Endocrinol. 6:920-26
113. 2 receptors. Proc. Natl. Acad. Sci. USA 88: 3135-39
114. Deleted in proof
115. 3 dopamine receptor produced through various patterns of alternative splicing. Biochem. Biophys. Res. Commun. 176:1584-92
116. Snyder, L. A., Roberts, J. L., Sealfon, S. C. 1991. Alternative transcripts of the rat and human dopamine D3 receptor. Biochem. Biophys. Res. Commun. 180:1031-35
117. 5 dopamine receptor genes. Genomics. Submitted
118. 5 receptor pseudogenes. Gene 109: 211-18
119. 2 receptor gene. Genomics 10:527-30
120. 2 dopamine receptor gene is not linked to manic-depression in three familes. Psychol. Genet. 1:55-62
121. 2 dopamine receptors. Arch. Gen. Psychol. 47:1073-77
122. 1 and flanking loci on chromosome 11q22-q23 in Tourette syndrome. Hum. Hered. 40:105-8
123. 2 dopamine receptor gene as candidate gene for schizophrenia. Ann. Gen. Psychol. 48:643-47
124. 2) in schizophrenics reveals three polymorphisms but no structural change in the receptor. Genomics 11:8-14
125. 2 receptor gene in alcoholism. J. Am. Med. Assoc. 263: 2055-60
126. 2 receptor gene and alcoholism. J. Am. Med. Assoc. 264: 3156-60
127. 1-adrenergic receptor subtype. J. Biol. Chem. 265:8183-89
128. 3-adrenergic receptor. Science 245:1118-21
129. 1 dopamine receptors coupled to inositol phosphate production and Ca mobilization in Xenopus oocytes. Proc. Natl. Acad. Sci. USA 87:2196-200
130. 2 dopamine receptor subtype. Proc. Natl. Acad. Sci. USA 86:10134-38